Report Detail

Pharma & Healthcare Global Growth Factors (Blood and Tissue) Market Professional Survey Report 2019

  • RnM3720905
  • |
  • 03 September, 2019
  • |
  • Global
  • |
  • 125 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Growth factor is natural substances produced by the body (hormones) or obtained from food (vitamins, minerals) that promote growth and development by directing cell maturation and differentiation and by mediating maintenance and repair of tissues; abnormalities in growth factors may be involved in benign and malignant neoplasia.
Growth factors are group of proteins, which play an important role in the stimulation of cellular differentiation and cell division in the human body. There are different kinds of growth factors present in the human body. Some of the major growth factors include insulin-like growth factors, platelet-derived growth factors, epidermal growth factors, and nerve growth factor. Moreover, some cytokines, such as small proteins secreted by one cell to regulate the function of another cell, also act as growth factors.
Growth factors are mainly used in the treatment of chronic diseases, such as anemia, renal disorders, cancer, etc. For instance, erythropoietin, which stimulates the growth of Red Blood Cells (RBCs), is used to treat anemia. Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) and Granulocyte Colony-Stimulating Factor (G-CSF) are involved in the stimulation of White Blood Cells (WBCs) in cancer patients. However, abnormal production of growth factors causes several diseases.

The global Growth Factors (Blood and Tissue) market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Growth Factors (Blood and Tissue) volume and value at global level, regional level and company level. From a global perspective, this report represents overall Growth Factors (Blood and Tissue) market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Growth Factors (Blood and Tissue) in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Growth Factors (Blood and Tissue) manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Amgen, Inc. (USA)
Bayer HealthCare Pharmaceuticals, Inc. (USA)
Biocon Ltd. (India)
Biogen, Inc. (USA)
BioMimetic Therapeutics LLC (USA)
Biopharm GmbH (Germany)
Bolder BioTechnology, Inc. (USA)
F. Hoffmann-La Roche AG (Switzerland)
Chugai Pharmaceutical Co. Ltd. (Japan)
Genentech, Inc. (USA)
FibroGen, Inc. (USA)
Johnson & Johnson (USA)
Janssen Biotech, Inc. (USA)
Lonza Group (Switzerland)
Merck Serono (Germany)
PeproTech, Inc. (USA)
Reliance GeneMedix Plc (UK)
Sangamo Therapeutics, Inc. (USA)
Sanofi (France)
Scil Proteins GmbH (Germany)
Teva Pharmaceutical Industries Ltd. (Israel)
Wockhardt Ltd. (India)

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins)
Tissue Growth Factors

Segment by Application
Hospital
Research lab


Table of Contents

    Executive Summary

      1 Industry Overview of Growth Factors (Blood and Tissue)

      • 1.1 Definition of Growth Factors (Blood and Tissue)
      • 1.2 Growth Factors (Blood and Tissue) Segment by Type
        • 1.2.1 Global Growth Factors (Blood and Tissue) Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Blood Growth Factors (Erythropoietins, Colony Stimulating Factors, Interferons, & Interleukins)
        • 1.2.3 Tissue Growth Factors
      • 1.3 Growth Factors (Blood and Tissue) Segment by Applications
        • 1.3.1 Global Growth Factors (Blood and Tissue) Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Research lab
      • 1.4 Global Growth Factors (Blood and Tissue) Overall Market
        • 1.4.1 Global Growth Factors (Blood and Tissue) Revenue (2014-2025)
        • 1.4.2 Global Growth Factors (Blood and Tissue) Production (2014-2025)
        • 1.4.3 North America Growth Factors (Blood and Tissue) Status and Prospect (2014-2025)
        • 1.4.4 Europe Growth Factors (Blood and Tissue) Status and Prospect (2014-2025)
        • 1.4.5 China Growth Factors (Blood and Tissue) Status and Prospect (2014-2025)
        • 1.4.6 Japan Growth Factors (Blood and Tissue) Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Growth Factors (Blood and Tissue) Status and Prospect (2014-2025)
        • 1.4.8 India Growth Factors (Blood and Tissue) Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Growth Factors (Blood and Tissue)
      • 2.3 Manufacturing Process Analysis of Growth Factors (Blood and Tissue)
      • 2.4 Industry Chain Structure of Growth Factors (Blood and Tissue)

      3 Development and Manufacturing Plants Analysis of Growth Factors (Blood and Tissue)

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Growth Factors (Blood and Tissue) Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Growth Factors (Blood and Tissue)
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Growth Factors (Blood and Tissue) Production and Capacity Analysis
      • 4.2 Growth Factors (Blood and Tissue) Revenue Analysis
      • 4.3 Growth Factors (Blood and Tissue) Price Analysis
      • 4.4 Market Concentration Degree

      5 Growth Factors (Blood and Tissue) Regional Market Analysis

      • 5.1 Growth Factors (Blood and Tissue) Production by Regions
        • 5.1.1 Global Growth Factors (Blood and Tissue) Production by Regions
        • 5.1.2 Global Growth Factors (Blood and Tissue) Revenue by Regions
      • 5.2 Growth Factors (Blood and Tissue) Consumption by Regions
      • 5.3 North America Growth Factors (Blood and Tissue) Market Analysis
        • 5.3.1 North America Growth Factors (Blood and Tissue) Production
        • 5.3.2 North America Growth Factors (Blood and Tissue) Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Growth Factors (Blood and Tissue) Import and Export
      • 5.4 Europe Growth Factors (Blood and Tissue) Market Analysis
        • 5.4.1 Europe Growth Factors (Blood and Tissue) Production
        • 5.4.2 Europe Growth Factors (Blood and Tissue) Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Growth Factors (Blood and Tissue) Import and Export
      • 5.5 China Growth Factors (Blood and Tissue) Market Analysis
        • 5.5.1 China Growth Factors (Blood and Tissue) Production
        • 5.5.2 China Growth Factors (Blood and Tissue) Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Growth Factors (Blood and Tissue) Import and Export
      • 5.6 Japan Growth Factors (Blood and Tissue) Market Analysis
        • 5.6.1 Japan Growth Factors (Blood and Tissue) Production
        • 5.6.2 Japan Growth Factors (Blood and Tissue) Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Growth Factors (Blood and Tissue) Import and Export
      • 5.7 Southeast Asia Growth Factors (Blood and Tissue) Market Analysis
        • 5.7.1 Southeast Asia Growth Factors (Blood and Tissue) Production
        • 5.7.2 Southeast Asia Growth Factors (Blood and Tissue) Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Growth Factors (Blood and Tissue) Import and Export
      • 5.8 India Growth Factors (Blood and Tissue) Market Analysis
        • 5.8.1 India Growth Factors (Blood and Tissue) Production
        • 5.8.2 India Growth Factors (Blood and Tissue) Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Growth Factors (Blood and Tissue) Import and Export

      6 Growth Factors (Blood and Tissue) Segment Market Analysis (by Type)

      • 6.1 Global Growth Factors (Blood and Tissue) Production by Type
      • 6.2 Global Growth Factors (Blood and Tissue) Revenue by Type
      • 6.3 Growth Factors (Blood and Tissue) Price by Type

      7 Growth Factors (Blood and Tissue) Segment Market Analysis (by Application)

      • 7.1 Global Growth Factors (Blood and Tissue) Consumption by Application
      • 7.2 Global Growth Factors (Blood and Tissue) Consumption Market Share by Application (2014-2019)

      8 Growth Factors (Blood and Tissue) Major Manufacturers Analysis

      • 8.1 Amgen, Inc. (USA)
        • 8.1.1 Amgen, Inc. (USA) Growth Factors (Blood and Tissue) Production Sites and Area Served
        • 8.1.2 Amgen, Inc. (USA) Product Introduction, Application and Specification
        • 8.1.3 Amgen, Inc. (USA) Growth Factors (Blood and Tissue) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Bayer HealthCare Pharmaceuticals, Inc. (USA)
        • 8.2.1 Bayer HealthCare Pharmaceuticals, Inc. (USA) Growth Factors (Blood and Tissue) Production Sites and Area Served
        • 8.2.2 Bayer HealthCare Pharmaceuticals, Inc. (USA) Product Introduction, Application and Specification
        • 8.2.3 Bayer HealthCare Pharmaceuticals, Inc. (USA) Growth Factors (Blood and Tissue) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Biocon Ltd. (India)
        • 8.3.1 Biocon Ltd. (India) Growth Factors (Blood and Tissue) Production Sites and Area Served
        • 8.3.2 Biocon Ltd. (India) Product Introduction, Application and Specification
        • 8.3.3 Biocon Ltd. (India) Growth Factors (Blood and Tissue) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Biogen, Inc. (USA)
        • 8.4.1 Biogen, Inc. (USA) Growth Factors (Blood and Tissue) Production Sites and Area Served
        • 8.4.2 Biogen, Inc. (USA) Product Introduction, Application and Specification
        • 8.4.3 Biogen, Inc. (USA) Growth Factors (Blood and Tissue) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 BioMimetic Therapeutics LLC (USA)
        • 8.5.1 BioMimetic Therapeutics LLC (USA) Growth Factors (Blood and Tissue) Production Sites and Area Served
        • 8.5.2 BioMimetic Therapeutics LLC (USA) Product Introduction, Application and Specification
        • 8.5.3 BioMimetic Therapeutics LLC (USA) Growth Factors (Blood and Tissue) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Biopharm GmbH (Germany)
        • 8.6.1 Biopharm GmbH (Germany) Growth Factors (Blood and Tissue) Production Sites and Area Served
        • 8.6.2 Biopharm GmbH (Germany) Product Introduction, Application and Specification
        • 8.6.3 Biopharm GmbH (Germany) Growth Factors (Blood and Tissue) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Bolder BioTechnology, Inc. (USA)
        • 8.7.1 Bolder BioTechnology, Inc. (USA) Growth Factors (Blood and Tissue) Production Sites and Area Served
        • 8.7.2 Bolder BioTechnology, Inc. (USA) Product Introduction, Application and Specification
        • 8.7.3 Bolder BioTechnology, Inc. (USA) Growth Factors (Blood and Tissue) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 F. Hoffmann-La Roche AG (Switzerland)
        • 8.8.1 F. Hoffmann-La Roche AG (Switzerland) Growth Factors (Blood and Tissue) Production Sites and Area Served
        • 8.8.2 F. Hoffmann-La Roche AG (Switzerland) Product Introduction, Application and Specification
        • 8.8.3 F. Hoffmann-La Roche AG (Switzerland) Growth Factors (Blood and Tissue) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Chugai Pharmaceutical Co. Ltd. (Japan)
        • 8.9.1 Chugai Pharmaceutical Co. Ltd. (Japan) Growth Factors (Blood and Tissue) Production Sites and Area Served
        • 8.9.2 Chugai Pharmaceutical Co. Ltd. (Japan) Product Introduction, Application and Specification
        • 8.9.3 Chugai Pharmaceutical Co. Ltd. (Japan) Growth Factors (Blood and Tissue) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Genentech, Inc. (USA)
        • 8.10.1 Genentech, Inc. (USA) Growth Factors (Blood and Tissue) Production Sites and Area Served
        • 8.10.2 Genentech, Inc. (USA) Product Introduction, Application and Specification
        • 8.10.3 Genentech, Inc. (USA) Growth Factors (Blood and Tissue) Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 FibroGen, Inc. (USA)
      • 8.12 Johnson & Johnson (USA)
      • 8.13 Janssen Biotech, Inc. (USA)
      • 8.14 Lonza Group (Switzerland)
      • 8.15 Merck Serono (Germany)
      • 8.16 PeproTech, Inc. (USA)
      • 8.17 Reliance GeneMedix Plc (UK)
      • 8.18 Sangamo Therapeutics, Inc. (USA)
      • 8.19 Sanofi (France)
      • 8.20 Scil Proteins GmbH (Germany)
      • 8.21 Teva Pharmaceutical Industries Ltd. (Israel)
      • 8.22 Wockhardt Ltd. (India)

      9 Development Trend of Analysis of Growth Factors (Blood and Tissue) Market

      • 9.1 Global Growth Factors (Blood and Tissue) Market Trend Analysis
        • 9.1.1 Global Growth Factors (Blood and Tissue) Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Growth Factors (Blood and Tissue) Regional Market Trend
        • 9.2.1 North America Growth Factors (Blood and Tissue) Forecast 2019-2025
        • 9.2.2 Europe Growth Factors (Blood and Tissue) Forecast 2019-2025
        • 9.2.3 China Growth Factors (Blood and Tissue) Forecast 2019-2025
        • 9.2.4 Japan Growth Factors (Blood and Tissue) Forecast 2019-2025
        • 9.2.5 Southeast Asia Growth Factors (Blood and Tissue) Forecast 2019-2025
        • 9.2.6 India Growth Factors (Blood and Tissue) Forecast 2019-2025
      • 9.3 Growth Factors (Blood and Tissue) Market Trend (Product Type)
      • 9.4 Growth Factors (Blood and Tissue) Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Growth Factors (Blood and Tissue) Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Summary:
        Get latest Market Research Reports on Growth Factors (Blood and Tissue). Industry analysis & Market Report on Growth Factors (Blood and Tissue) is a syndicated market report, published as Global Growth Factors (Blood and Tissue) Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Growth Factors (Blood and Tissue) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        $3,500.00
        $5,250.00
        $7,000.00
        2,628.50
        3,942.75
        5,257.00
        3,136.00
        4,704.00
        6,272.00
        503,790.00
        755,685.00
        1,007,580.00
        292,495.00
        438,742.50
        584,990.00
        Credit card Logo

        Related Reports


        Reason to Buy

        Request for Sample of this report